←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Peptide Drug Conjugate
Jeffrey Hinton
PhD
🏢Bicycle Therapeutics🌐United Kingdom
Senior Vice President, Chemistry
25
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Jeffrey Hinton contributes to the development of bicyclic peptide drug conjugates at Bicycle Therapeutics, a platform producing small high-affinity peptide warheads for tumor targeting. His work supports programs targeting EphA2 and MT1-MMP in solid tumors. He is a leader in bicyclic peptide chemistry.
Share:
🧪Research Fields 研究领域
bicyclic peptides
peptide drug conjugates
EphA2 targeting
MT1-MMP targeting
cancer conjugate design
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Jeffrey Hinton 的研究动态
Follow Jeffrey Hinton's research updates
留下邮箱，当我们发布与 Jeffrey Hinton（Bicycle Therapeutics）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment